USPTO serial 79411612
PENZYME
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 27, 2026
- Examiner
- SEVERSON, JUSTIN
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with PENZYME?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Maurine Knutsson
Maurine Knutsson Knutsson IP ABNelinsgatan 14Norrkoping, 603 45SWEDENGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | enzyme substrates, other than for medical or veterinary purposes; activator enzymes for use in the manufacture of mouth sprays, nose sprays, pharmaceuticals, nutraceuticals, food, cosmetic preparations, cosmetic formulations, skin care preparations, pharmaceutical preparations, creams and lotions for skin care and skin treatment, dental preparations, dentifrices, hair care preparations, soaps, bath salts, cosmetics, essential oils, perfumes, and natural cosmetics; enzyme stabilizers; enzymes for scientific purposes; enzymes for industrial purposes; enzyme preparations for industrial purposes; enzyme substrates for scientific purposes; purified enzymes for industrial use; enzymes, other than for medical or veterinary use | ACTIVE | — |
| 003 | non-medicated skin care preparations; skin moisturizing gel and skin lotions; hair-care preparations; dentifrices, dental care preparations, namely, dental bleaching gels and creams, and non-medicated dental rinses; beauty, skin, bath, and bar soaps; perfumes; essential oils; cosmetics; natural cosmetics | ACTIVE | — |
| 005 | pharmaceutical preparations for skin care and wounds; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for treating allergies, hypertension, sunburn, asthma, hypoglycaemia, dandruff, chemical imbalances, diabetes, halitosis, and skin disorders; pharmaceutical preparations for treatment and prevention of cardiovascular, oncological, pulmonary, kidney, autoimmune, metabolic, endocrine, musculoskeletal, genitourinary, neurological, gastrointestinal, and hepatological diseases and disorders; pharmaceutical preparations for the treatment and prevention of damaged skin and tissue, acne, infectious diseases, pain, inflammation, sepsis, alopecia, obesity, cognitive disorders, sleep disorders, psychiatric diseases and disorders, viral infections and diseases, and bacterial infections and diseases; veterinary preparations, namely, antioxidants and pain relief medication; veterinary preparations for treatment of intestinal bacteria; veterinary pharmaceutical preparations for treatment and prevention of cardiovascular, oncological, pulmonary, kidney, autoimmune, metabolic, endocrine, musculoskeletal, genitourinary, neurological, gastrointestinal, and hepatological diseases and disorders; veterinary pharmaceutical preparations for the treatment and prevention of damaged skin and tissue, acne, infectious diseases, pain, inflammation, sepsis, alopecia, obesity, cognitive disorders, sleep disorders, psychiatric diseases and disorders, viral infections and diseases, and bacterial infections and diseases; medical preparations for preventing or treating colds being viral infections and diseases; medical preparations, gel and lotions for skin treatment; medicated mouth care preparations; chewing gums for medical purposes; sanitary preparations for medical purposes; dietetic substances adapted for medical use, namely, nutraceuticals for treatment and prevention of cardiovascular, oncological, pulmonary, kidney, autoimmune, metabolic, endocrine, musculoskeletal, genitourinary, neurological, gastrointestinal, and hepatological diseases and disorders; dietetic substances adapted for medical use, namely, nutraceuticals for the treatment and prevention of damaged skin and tissue, acne, infectious diseases, pain, inflammation, sepsis, alopecia, obesity, cognitive disorders, sleep disorders, psychiatric diseases and disorders, viral infections and diseases, and bacterial infections and diseases; dietetic substances adapted for medical use, namely, nutraceuticals for use as a dietary supplement; dietetic supplements, beverages, foods, sugar, sugar substitutes, and confectionaries adapted for medical purposes and medical use; dietetic preparations adapted for medical purposes; medicinal drinks; vitamin preparations and mineral supplements; medicated bath preparations and medicated bath salts; medical plasters; materials for dressings, namely, bandages for dressings, burn dressings, first aid dressings, medical dressings, sterilized dressings, and wound dressings; anti-inflammatory sprays; disinfectants; fungicides, herbicides; enzymes and enzyme preparations for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Enzymatica AB (publ)
- Other trademarks owned by Enzymatica AB (publ)
- Other trademarks owned by Enzymatica AB (publ)
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Similar marks named PENZYME
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 20, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 4, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 4, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 21, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 4, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 4, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 27, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 27, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 27, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 11, 2025 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 9, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 9, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 3, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 26, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 25, 2025 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 12, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 12, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 12, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 12, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 12, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 22, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 22, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 22, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 7, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 21, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 21, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 28, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 26, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 25, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 24, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 9, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 9, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 5, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |